CMET-03. PHASE 1 TRIAL OF OSIMERTINIB WITH STEREOTACTIC RADIOSURGERY IN EGFR MUTANT LUNG CANCER BRAIN METASTASIS

BACKGROUND: Brain metastases (BM) occurs in 25–40% of patients with non-small cell lung cancer (NSCLC). Traditionally patients with brain metastases were treated with whole brain radiation therapy (WBRT), stereotactic radiosurgery (SRS) and surgical resection. Historically, BM is associated with dis...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Thapa, Bicky, Chao, Samuel, Pennell, Nathan, Peereboom, David, Ahluwalia, Manmeet
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2018
Konular:
Abstracts
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216839/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.216
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller